Impact of Daily Bathing With Chlorhexidine in the Critical Patient
Healthcare Associated Infections
About this trial
This is an interventional health services research trial for Healthcare Associated Infections focused on measuring Chlorhexidine baths, Critical patient, Healthcare associated infections, Critical care environment, Patient colonization
Eligibility Criteria
Inclusion Criteria:
- Any patient admitted to the medical intensive care unit
- Any patient with less than 48 hours in the medical intensive care unit
- Patient's age 18 years or older
Exclusion Criteria:
- Patients with burns greater than 20% body surface
- Pregnancy
- Patients with recorded allergy history to chlorhexidine
Elimination Criteria:
- Patient refuses participation in the study
- Patient develops severe reaction to chlorhexidine, defined as the sudden appearance of rash and/or pruritus.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Experimental
Placebo Comparator
Chlorhexidine
Placebo
Intervention: daily baths with chlorhexidine wipes, oral spray and shampoo. This arm will receive daily bathing with chlorhexidine wipes at 2% (CLORHEXI-WIPES ONE-STEP, G70 Antisepsis, León, México) plus an oral spray application of chlorhexidine chlorhydrate at 0.12%. For scalp washing, a chlorhexidine shampoo at 0.12% concentration will be applied.
Intervention: daily baths with placebo wipes, oral spray and standard shampoo. This arm will receive wipes with the same components as arm #1 plus an oral spray application with the same components except chlorhexidine. For scalp, a standard shampoo will be used. These products will have the same labels and smell as the products in arm #1.